InvestorsObserver is giving Syndax Pharmaceuticals Inc (SNDX) an Analyst Rating Rank of 60, meaning SNDX is ranked higher by analysts than 60% of stocks. The average price target for SNDX is $27.75 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating SNDX a Strong Buy today. Find out what this means to you and get the rest of the rankings on SNDX!